Amneal Pharmaceuticals Inc - Ordinary Shares - Class A

NYSE:AMRX   4:00:00 PM EDT
2.41
+0.04 (+1.69%)
Products

Amneal Announces U.S. FDA Filing Acceptance Of New Drug Application For Ipx203

Published: 11/11/2022 13:17 GMT
Amneal Pharmaceuticals Inc - Ordinary Shares - Class A (AMRX) - Amneal Announces U.S. FDA Filing Acceptance of New Drug Application for Ipx203 for the Treatment of Parkinson’s Disease.
Amneal Pharmaceuticals Inc - FDA Has Assigned a Prescription Drug User Fee Act (pdufa) Date of June 30, 2023.
Amneal Pharmaceuticals - Ipx203 Could Offer People Living With Parkinson's Disease Longer Duration of Symptom Control With Less Frequent Dosing.